Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Chapter 17 - Management of Monoamniotic Twins

  • Edited by Leanne Bricker, Julian N. Robinson, Baskaran Thilaganathan, St George's Hospital Medical School, University of London
  • Book:
    Management of Multiple Pregnancies
    Published online:
    11 October 2022
    Print publication:
    27 October 2022, pp 181-187

  • Summary

    In monochorionic monoamniotic twin pregnancies, two fetuses share a single placenta and a single amniotic cavity. This unique anatomic configuration, although rare, puts them at high risk for a number of complications including structural anomalies, twin-twin transfusion syndrome, selective intra-uterine growth restriction and cord accidents. Early diagnosis and patient counselling are therefore crucial. Level 1 evidence on the optimal management of monoamniotic twins is lacking, but observational studies provide some guidance for best practice. In uncomplicated monoamniotic twins, after viability, fetal mortality is less than 5% if close surveillance is initiated. This can be done in either an inpatient or outpatient setting. If all goes well, monoamniotic twins should be delivered from 33 weeks’ gestation as, at that timepoint, the risk of in utero death is larger than the risk of (non-respiratory) neonatal complications.